“…The NO-scavenger PTIO has been used as a specific inhibitor of AOA (Kozlowski, Stieglmeier, et al, 2016;Shen et al, 2013;Yan et al, 2012), but also inhibits comammox bacteria (Kits et al, 2019), and simvastatin can specifically inhibit AOA (Zhao, Bello, Meng, Prosser, & Gubry-Rangin, in press). An alternative explanation is redox balancing, in which electrons generated by hydroxylamine dehydrogenase are shuttled to denitrification enzymes when they exceed the capacity of terminal oxidases (Hink, Lycus, et al, 2017). Higher yields are observed with increasing NH 4 + concentration, potentially due to a lower reaction rate of hydroxylamine dehydrogenase than AMO, leading to accumulation of hydroxylamine, which is subsequently transformed abiotically to N 2 O (Hink, Lycus, et al, 2017).…”